BNET Industries
Last Fiscal Year Sales:$35.9B
- Public
- DE
Dow Jones Description
Bayer is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Our products and services are designed to benefit people and improve their quality of life. At the same time we want to create value through innovation, growth and improved earning power. We already successfully reorganized the Bayer Group and further streamlined our portfolio to create a new Bayer that is focused on its corporate strengths, its customers and the markets of the future. To help us achieve this goal, we then carried out a strategic realignment in order to concentrate in future on three high-potential, agile subgroups with largely independent operations: HealthCare, CropScience and MaterialScience, supported by three service companies. Our operating companies give us the access we need to the growth markets of the future. As an inventor company, we plan to continue setting trends in research-intensive areas. Innovations are the foundation for our competitiveness and our corporate growth, and thus for our success in the future. We believe our technical and commercial expertise entails a duty to contribute to sustainable development ? a principle we wholeheartedly endorse, mindful of its social, ethical and environmental elements. In awareness of our responsibilities as a corporate citizen, we define economy, ecology and social commitment as objectives of equal rank. We seek to retain society?s confidence through performance, flexibility and open communication as we work in pursuit of our overriding corporate goals: to steadily create corporate value and generate high value-added for the benefit of our stockholders, our employees and the community in every country in which we operate.
Director, Finance
Klaus KuhnNumber of Employees 122,100
Peer Companies
NAICS Code Plastics Material and Resin Manufacturing: 325211
Recent Events
-
Bayer and United Nations Environment Programme Launch 19th Annual International Children's...
-
Bayer Consumer Care Launches CitracalR Calcium Plus Heart Health
-
German drug, chemical company Bayer's Q3 net income falls 10 per cent
-
Bayer, US Onyx launch phase III trial of Nexavar in patients with non-responsive thyroid cancer
-
BRIEF-Credit Suisse raises targets on European pharma cos
-
Bayer accused of hiding Yaz contraceptive risk
-
Bayer downgraded to neutral from buy at UBS
-
Abbott Laboratories to acquire Solvay Pharmaceuticals
-
Bayer's contested kidney cancer drug shows benefit
-
Bayer names new CEO
-
Bayer Introduces CONTOUR USB - The First Blood Glucose Meter With Unique Plug & Play...
-
Bayer's next CEO has a year to prepare Today
-
Bayer AG tabs outsider as CEO's successor
-
Bayer Unveils Management Shuffle
News & Analysis
Filter by
bayer ag and berlin - All News and Analysis
Bayern look to avoid Bavarian banana skin at Nuremberg
- 2008-03-29
BERLIN AFP — More than a year after his return to coach Bayern Munich, Ottmar Hitzfeld takes the Bundesliga leaders to relegation-threatened Bayer Leverkusen knowing the title is now theirs to lose. When Hitzfeld returned in January 2007 for his second spell in charge, Bayern were about to limp...
Refs are too hard on us says Bayern's Rummenigge
- 2008-02-13
BERLIN AFP — Despite his team's three-point lead at the top of the Bundesliga, Bayern Munich boss Karl-Heinz Rummenigge insists the German giants are treated harshly by referees in the domestic league. Rummenigge says referee Thorsten Kinhoefer's decision to disallow a goal by Bayern striker Luca Toni in the...
Bayer to cut 950 jobs in Berlin following Schering takeover
- 2007-02-28
LEVERKUSEN, Germany AFP — German chemicals and pharmaceutcials giant Bayer said Wednesday that it planned to axe 950 jobs in Berlin following its acquisition of drug-maker Schering, which is based in the German capital. Schering employs a workforce of about 5,500 in Berlin. The cuts, which would not...
Bayer to axe 1,000 jobs at Schering
- 2007-02-18
BERLIN AFP — Bayer, the German chemicals and pharmaceuticals specialist, plans to axe 1,000 jobs at its Berlin-based drug maker Schering, the daily Der Tagesspiegel reported in an advance copy of its Monday issue. The company was to inform its Berlin staff on March 2 about the job cuts,...
Bayern slip up again
- 2007-01-30
BERLIN AFP — Bayern Munich slipped up badly when Felix Magath's champions were held to an embarrassing goalless draw by lowly Vfl Bochum. This result coming after their 3-2 loss to Borussia Dortmund in their opening match of 2007 left them struggling in fourth, four points off leaders Werder...
Borussia sack Van Marwijk
- 2006-12-18
BERLIN AFP — Borussia Dortmund have announced that Dutch coach Bert van Marwijk had been sacked paying the price of the club's lowly league position. Van Marwijk had already said that he would leave Borussia at the end of the year despite having a contract that took him through until...
Stuttgart go third with Gladbach win
- 2006-11-26
BERLIN AFP — VfB Stuttgart moved up to third two points behind leaders Schalke 04 with a 1-0 win over Borussia Monchengladbach. Brazilian forward Cacau scored after just six minutes to give the hosts the early initiative and they held on for their eighth win of the season For Gladbach...
Schering net profit up in first quarter
- 2006-04-19
BERLIN AFP — Schering, the German pharmaceuticals specialist, has said that strong demand for its best-selling multiple sclerosis drug Betaferon and its Yasmin contraceptive pill boosted earnings in the first three months of the current year. Schering, currently being taken over by bigger rival Bayer, said in a statement...
Schering boss welcomes takeover, regrets loss of independence
- 2006-03-25
BERLIN AFP — German pharmaceutical group Bayer's purchase of rival Schering makes sense commercially and strategically, Schering boss Hubertus Erlen said in an interview, while regretting his company's loss of independence. Bayer announced a cash offer for Schering of 86.0 euros (103 dollars) per share late on Thursday, presenting...
Brazilian Athirson signs for Leverkusen
- 2005-06-09
BERLIN AFP — Brazilian defender Athirson has signed a three-year contract with Bayer Leverkusen for 800,000 euros, the German first division club announced. The 28-year-old Athirson, who played for Brazilian first division club Cruzeiro Belo Horizonte last season, is expected to play on the left flank at his new...
- 1
- 2
Decision Makers
| Name (plus bio) | Position |
|---|---|
| Klaus Kuhn | Director, Finance |
| Richard Pott | Director, Strategy and Human Resources |
| Wolfgang Plischke | Director, Innovation, Technology and Environment |
| Hartmut Klusik | Head, Product Supply |
| Gary S Balkema | Executive Committee Member |
Board of Directors
| Name (plus bio) | Position |
|---|---|
| Arthur J Higgins | Chairman, HealthCare |
| Werner Wenning | Executive Chairman |
| Klaus Kleinfeld | Board of Directors |
| Paul Achleitner | Board of Directors |
| Organization | Position | Status |
|---|---|---|
| Bayer AG | Director, Finance | Current |
| University of South Carolina | MBA | Former |
| Organization | Position | Status |
|---|---|---|
| Bayer AG | Director, Strategy and Human Resources | Current |
| University of Cologne | doctorate in physics | Former |
| Organization | Position | Status |
|---|---|---|
| Bayer AG | Director, Innovation, Technology and Environment | Current |
| Bayer HealthCare AG | Manager | Current |
| Bayer HealthCare AG | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Bayer AG | Head, Product Supply | Current |
| Organization | Position | Status |
|---|---|---|
| Bayer AG | Chairman, HealthCare | Current |
| Enzon Pharmaceuticals, Inc. | CEO | Former |
| Pharmaceutical Research and Manufacturers of America | member | Former |
| Bayer HealthCare, Animal Health Division | Chairman | Former |
| Enzon Pharmaceuticals, Inc. | Chairman | Former |
| Organization | Position | Status |
|---|---|---|
| Bayer AG | Executive Chairman | Current |
| Henkel AG & Co. KGaA | Supervisory Board | Current |
Klaus Kleinfeld is president and chief executive officer of Alcoa. He joined the company in 2007 as president and chief operating officer and seven months later assumed CEO responsibilities. He has served on Alcoa's board of directors since 2003. Alcoa is a world leader in the production and management of a very sustainable product: aluminum. Nearly 75% of the aluminum ever produced since 1888 is still in use today. The company has been a technology leader since its beginning, providing more than 90% of the aluminum alloys used in aircraft and space flight; helping making automobiles lighter, without compromising safety or performance; manufacturing sheet that created the ultimate recyclable container, the aluminum beverage can; and providing building and construction industry materials that help further the green building movement. In addition, to serving customers in these markets, Alcoa also markets wheels, fastening systems, precision and investment castings, and building systems. The company has 97,000 employees in 34 countries. Before coming to Alcoa, Mr. Kleinfeld had a 20-year career with Siemens, the global electronics and industrial conglomerate, based in the U.S. and Germany, where he served as chief executive officer of Siemens AG starting in 2005. During his tenure, Mr. Kleinfeld presided over a dramatic transformation of the company, reshaping the company's portfolio around three high growth areas, resulting in increase of revenues and market capitalization nearly doubled. Prior to his service on the Managing Board of Siemens AG, Mr. Kleinfeld was President and Chief Executive Officer of Siemens Corporation, its U.S. arm and the company's largest region. In addition to serving on Alcoa's board, he is a member of the board of Bayer AG. On the personal front, Mr. Kleinfeld was born in Bremen, Germany and educated at the University of Goettingen and University of Wuerzburg, both in Germany. He holds a Ph.D in strategic management and master's degree in business administration. In his leisure time, he enjoys skiing, tennis, the arts and is a marathon runner. Mr. Kleinfeld resides in New York with his wife and children.
| Organization | Position | Status |
|---|---|---|
| Alcoa, Inc. | President & Chief Executive Officer | Current |
| Bayer AG | Board of Directors | Current |
| Alcoa, Inc. | Board of Directors | Current |
| Siemens AG | President & CEO | Former |
| Siemens Corporation | Chief Executive Officer | Former |
| Alcoa, Inc. | Chief Operating Officer | Former |
| Siemens Corporation | Chief Operating Officer | Former |
| Siemens AG | Chief Operations Officer, U.S. | Former |
| Siemens AG | Executive Vice President | Former |
| Siemens AG | Audit Committee Principal | Former |
| Citigroup Inc. | Board of Directors | Former |
| Siemens AG | Board of Directors | Former |
| Siemens Corporation | member | Former |
| Organization | Position | Status |
|---|---|---|
| Allianz SE | Executive Director, Finance | Current |
| Bayer AG | Board of Directors | Current |
| Goldman, Sachs & Co. | Vice President, Mergers & Acquisitions | Former |
| Bain & Company | Manager, Strategy Consulting | Former |
| Organization | Position | Status |
|---|---|---|
| Bayer AG | Executive Committee Member | Current |
| Bayer HealthCare, Animal Health Division | President, Worldwide Bayer Consumer Care Division | Former |
| Fairleigh Dickinson University | master of business administration degree | Former |
Executive News
-
Report from Europe: U.S. Close vs. China Rebound
-
Alcoa Named Component of Dow Jones Sustainability Index for Eighth Consecutive Year
-
Alcoa says global aluminium demand to fall 5.5 pct -Bloomberg
-
Siemens To Settle Bribery Charges with Three Former Execs
-
Siemens poised to settle with ex-managers
-
UPDATE 1-Siemens poised to settle with ex-managers
-
UPDATE 1-Siemens poised to settle with ex-managers
-
Bayer AG (BAY.F) May Be Ready for Deals After Lost Intervet Bid
-
Inventories May Temper Aluminum Rally
Industry Transcripts by Seeking Alpha
-
Deere & Company F4Q09 (Qtr End 10/31/09) Earnings Call Transcript
on Nov 25, 2009about DE
-
Brown Shoe Co. Inc. Q3 2009 Earnings Call Transcript
on Nov 24, 2009about BWS
-
Daktronics Inc. F2Q10 (Qtr End 31/10/09) Earnings Call Transcript
on Nov 24, 2009about DAKT
-
Haynes International Inc. F4Q09 (Qtr End 09/30/09) Earnings Call Transcript
on Nov 24, 2009about HAYN
-
Valspar Corp. F4Q09 (Qtr End 30/10/09) Earnings Call Transcript
on Nov 23, 2009about VAL
Glass Door
Bayer AG
IndustryTop Rated
